基于18F-FDG PET/CT的影像组学列线图预测儿童神经母细胞瘤骨髓受累:一项两中心研究
回顾性分析两中心241例儿童神经母细胞瘤患者的18F-FDG PET/CT数据,构建基于肿瘤和轴向骨骼的影像组学模型及结合临床因素的列线图。轴向骨骼影像组学模型AUC优于肿瘤模型,列线图在训练集、内部验证集和外部验证集的AUC分别为0.932、0.887和0.733。
要点
- 轴向骨骼影像组学模型预测骨髓受累的AUC为0.900,优于肿瘤模型(AUC 0.773)。
- 结合临床风险因素与轴向骨骼影像组学特征的列线图在训练集AUC达0.932。
- 列线图外部验证集AUC为0.733,提示中心间性能存在差异。
核心结论
- 基于轴向骨骼的影像组学模型在预测骨髓受累方面优于基于肿瘤的模型,结合临床风险因素的列线图进一步提高了预测性能。
研究设计与样本
- 回顾性两中心研究,共纳入241例接受18F-FDG PET/CT检查的神经母细胞瘤患儿;中心A(n=200)随机分为训练集(n=140)和内部验证集(n=60),中心B(n=41)为外部验证集;每个患者勾画肿瘤和轴向骨骼两个感兴趣区,提取临床因素和影像组学特征构建模型,以AUC评估性能。
诊断标准与关键数值
- 训练集中,基于肿瘤的影像组学模型AUC为0.773,基于轴向骨骼的影像组学模型AUC为0.900,临床模型AUC为0.858;结合临床风险因素和轴向骨骼影像组学特征的列线图在训练集、内部验证集和外部验证集的AUC分别为0.932、0.887和0.733。
临床应用与阅片要点
- 作者指出基于轴向骨骼的影像组学模型在预测骨髓受累方面表现优于基于肿瘤的模型。
- 作者指出结合轴向骨骼影像组学特征与临床风险因素的列线图提高了预测性能。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To assess the predictive ability of an 18F-FDG PET/CT-based radiomics nomogram for bone marrow involvement in pediatric neuroblastoma.
MATERIALS AND METHODS: A total of 241 neuroblastoma patients who underwent 18F-FDG PET/CT at two medical centers were retrospectively evaluated. Data from center A (n = 200) were randomized into a training cohort (n = 140) and an internal validation cohort (n = 60), while data from center B (n = 41) constituted the external validation cohort. For each patient, two regions of interest were defined using the tumor and axial skeleton. The clinical factors and radiomics features were derived to construct the clinical and radiomics models. The radiomics nomogram was built by combining clinical factors and radiomics features. The area under the receiver operating characteristic curves (AUCs) were used to assess the performance of the models.
RESULTS: Radiomics models created from tumor and axial skeleton achieved AUCs of 0.773 and 0.900, and the clinical model had an AUC of 0.858 in the training cohort. By incorporating clinical risk factors and axial skeleton-based radiomics features, the AUC of the radiomics nomogram in the training cohort, internal validation cohort, and external validation cohort was 0.932, 0.887, and 0.733, respectively.
CONCLUSION: The axial skeleton-based radiomics model performed better than the tumor-based radiomics model in predicting bone marrow involvement. Moreover, the radiomics nomogram showed that combining axial skeleton-based radiomics features with clinical risk factors improved their performance.
引用
- Feng L, Zhou Z, Liu J, et al. 18F-FDG PET/CT-Based Radiomics Nomogram for Prediction of Bone Marrow Involvement in Pediatric Neuroblastoma: A Two-Center Study. Acad Radiol. 2023. PMID: 37643929. doi:10.1016/j.acra.2023.07.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。